Stephen Roberts

Dr. Stephen Roberts is a Professor at Oregon Health & Science University (OHSU) School of Medicine, serving as Head of the Pediatric Hematology/Oncology Division and Associate Director of Pediatric Oncology at the Knight Cancer Institute. His clinical expertise centers on pediatric cancer care with specialized focus on neuroblastoma, a rare adrenal gland tumor.

Dr. Roberts' educational background includes:

• B.S. from Wheaton College (1993)
• M.D. from Northwestern University Feinberg School of Medicine (1998)
• Pediatrics Residency at Tripler Army Medical Center (2001)
• Pediatric Hematology/Oncology Fellowship at OHSU (2004)

Board-certified in General Pediatrics and Pediatric Hematology/Oncology, his research investigates neuroblastoma development mechanisms to identify less toxic treatments. Current work explores immunotherapy approaches, genomic characterization of tumor subtypes, and developmental pathways in neuroblastoma pathogenesis.

Analysis of his 15 most recent publications reveals dominant research themes in neuroblastoma immunotherapy (particularly anti-GD2 antibodies), genomic profiling of high-risk disease, developmental biology modeling using iPSCs, and metastatic evolution. Key trends include therapeutic targeting of adrenergic circuitry, ALK inhibitors, and combination strategies to overcome treatment resistance.

Dr. Roberts maintains active membership in the American Society of Pediatric Hematology Oncology, American Association of Cancer Research, Advances in Neuroblastoma Research Association, International Society of Pediatric Oncology, and Children's Oncology Group. While no specific scientific awards are documented, his leadership roles reflect professional recognition.

As division head and laboratory principal investigator, Dr. Roberts directs the childhood cancer research program at OHSU, overseeing clinical trials and translational research. His team collaborates extensively with national consortia including Memorial Sloan Kettering Cancer Center where he previously worked for 11 years.

Dr. Roberts leads a dedicated neuroblastoma research laboratory within the OHSU Knight Cancer Institute, focusing on developmental mechanisms and therapeutic vulnerabilities. His team utilizes genomic, stem cell, and clinical trial approaches to advance precision medicine for pediatric cancer patients.